{"code":"HSC","codeName":"Health and Safety Code","section":"439.905","citation":"Health & Saf. Code, § 439.905","status":"in-force","lawOn":"2026-09-28","headings":[{"name":"DIVISION 1. ADMINISTRATION OF PUBLIC HEALTH [135. - 1179.102.]","url":"https://blackletter.si/health-and-safety-code/division-1"},{"name":"PART 1.6. HEALTH RESEARCH FAIRNESS [439.900. - 439.906.]","url":"https://blackletter.si/health-and-safety-code/division-1/part-1.6"}],"history":"Added by Stats. 1991, Ch. 792, Sec. 1.","effective":null,"html":"<p>It is the intent of the Legislature to encourage research on the effectiveness of RU-486 (mifepristone) in treating breast and ovarian cancer, meningioma, endometriosis, Cushing’s syndrome, osteoporosis, diabetes, and AIDS.</p>","text":"It is the intent of the Legislature to encourage research on the effectiveness of RU-486 (mifepristone) in treating breast and ovarian cancer, meningioma, endometriosis, Cushing’s syndrome, osteoporosis, diabetes, and AIDS.","otherVersions":[],"url":"https://blackletter.si/health-and-safety-code/health-research-fairness-439-905","source":"California Legislative Information bulk export (pubinfo)"}